Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIRTUE trial of paricalcitol added to ramipril and sodium diet strategies in proteinuric chronic kidney disease
NL-OMON22539Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jan 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of paricalcitol in chronic kidney disease (CKD), proteinuria and albuminuria, sponsored by University Medical Center Groningen. Planned start Jan 2012; status: not yet recruiting.
02
Drugs
paricalcitol
03
Conditions
chronic kidney disease (CKD)proteinuriaalbuminuria
Beyond the preview
Go deeper on NL-OMON22539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22539.